EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease

Abstract

Authors

K. Degeling R.Z. Hayeems T. Tagimacruz K.V. MacDonald T.A. Seeger T. Hartley K.M. Boycott F.P. Bernier R. Mendoza-Londono D. Marshall